Abbott fined Rs 96 lakh for profiteering from GST

Economic Times

The anti-profiteering body has held that US pharmaceutical company  Abbott Healthcare did not pass on the benefits of the goods and services tax to customers after the new regime started in July 2017 and the rate was further reduced in November that year.  Abbott had instead increased the price of a cream after  GST became effective, the  National Anti-profiteering Authority (N…

Sign in to read the full article

Create a free account or sign in to access the complete content.